Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

SELL
$13.06 - $15.0 $8,750 - $10,050
-670 Reduced 38.89%
1,053 $15,000
Q4 2023

Feb 13, 2024

SELL
$12.02 - $13.41 $7,055 - $7,871
-587 Reduced 25.41%
1,723 $23,000
Q3 2023

Nov 14, 2023

SELL
$11.6 - $12.52 $13,606 - $14,685
-1,173 Reduced 33.68%
2,310 $28,000
Q2 2023

Aug 21, 2023

BUY
$12.02 - $13.07 $41,865 - $45,522
3,483 New
3,483 $42,000
Q2 2018

Aug 14, 2018

SELL
$3.86 - $7.61 $77,423 - $152,641
-20,058 Closed
0 $0
Q3 2017

Nov 13, 2017

BUY
$9.13 - $11.72 $183,129 - $235,079
20,058
20,058 $292,000

Others Institutions Holding MACK

About MERRIMACK PHARMACEUTICALS INC


  • Ticker MACK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 13,410,200
  • Market Cap $203M
  • Description
  • Merrimack Pharmaceuticals, Inc. operates as a biopharmaceutical company. The company was incorporated in 1993 and is headquartered in Cambridge, Massachusetts.
More about MACK
Track This Portfolio

Track California State Teachers Retirement System Portfolio

Follow California State Teachers Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of California State Teachers Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California State Teachers Retirement System with notifications on news.